Dongjun N. Lin
No.107 Yanjiang West Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
LSP1 is a prognostic biomarker associated with apoptosis in acute myeloid leukemia.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: December 10, 2025
Association between systemic immune-inflammatory markers and monoclonal gammopathy of undetermined significance in the elderly population: findings from the National health and nutrition examination survey.
Journal: Clinical and experimental medicine
Published: November 02, 2025
Induction of Apoptosis and Activation of Endoplasmic Reticulum Stress by SJ6986 in Diffuse Large B-cell Lymphoma.
Journal: Anti-cancer agents in medicinal chemistry
Published: April 30, 2025
Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.
Journal: Experimental hematology & oncology
Published: April 22, 2025
Arming Abraxane With Cationic Spermidine Conjugate and Homologous Cell Membrane for Enhanced Triple-Negative Breast Cancer Therapy.
Journal: Advanced healthcare materials
Published: April 11, 2025
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.
Journal: British journal of haematology
Published: January 08, 2025
Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-associated subpopulation of B cells: a multicenter prospective study.
Journal: EBioMedicine
Published: October 18, 2024
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph+ acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study.
Journal: American journal of hematology
Published: July 14, 2024
Effects of chain lengths and backbone chirality on the bone-targeting ability of poly(glutamic acid)s.
Journal: Biomaterials science
Published: June 24, 2024
Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia.
Journal: Journal of cancer research and clinical oncology
Published: May 27, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 30, 2024
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study.
Journal: Journal of internal medicine
Published: October 29, 2023
Last Updated: 09/26/2026